Dongwha's antimicrobial agent wins excellent patent technology award

Published: 2007-12-27 06:59:00

Updated: 2007-12-27 06:59:00

Donwha Pharm earned a state-of-the-art patent technology award for its novel quinolone carboxy derivative (zabofloxacin, DW224a) on December 21, following the Presidential Award in 2007 Health Industry and Technology Exhibition of Korea (HITEK) on December 6.

Zabofloxacin is a fluoroquinolone antibiotic with enhanced in-vitro activity against Streptococcus pneumoniae, including strains resis...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.